cover image - Pharmacology - Elsevier eBook on VitalSource, 12th Edition
ISBN: 9780443116407
Copyright: 2026
Publication Date: 03-25-2025
Page Count: 848
Imprint: Saunders
List Price: $109.99

Pharmacology - Elsevier eBook on VitalSource, 12th Edition

by Linda E. McCuistion, PhD, MSN, RN, Kathleen Vuljoin DiMaggio, MSN, RN, Mary B. Winton, PhD, MSN, RN and Jennifer J. Yeager, PhD, MSN, RN

Elsevier eBook on VitalSource

cover image - Pharmacology - Elsevier eBook on VitalSource, 12th Edition
ISBN: 9780443116407
Copyright: 2026
Publication Date: 03-25-2025
Page Count: 848
Imprint: Saunders
List Price: $109.99
Was $109.99

Now $96.79

Or $0.00 with a valid access code
**Selected for 2025 Doody’s Core Titles® in Pharmacology**

Gain a solid understanding of nursing pharmacology and patient-centered medication safety! Pharmacology: A Patient-Centered Nursing Process Approach, 12th Edition, makes it easy to learn the principles of nursing pharmacology and drug dosage calculation. A clear guide to pharmacotherapy and safe drug administration, this popular book uses drug prototypes to provide need-to-know information about key drugs, including dosage, side effects, interactions, and more. Nursing Process/Clinical Judgment summaries enhance your skills in applying clinical judgment skills for safe patient care. Written by a team of nursing experts led by Linda McCuistion, this time-tested textbook provides the nursing pharmacology knowledge you need to succeed on the Next-Generation NCLEX® Exam and administer drugs safely.
    • NEW! The latest FDA drug approvals, withdrawals, and drug uses are included throughout
    • NEW! Content updates reflect the most current evidence-based care and the 2021 AACN Essentials
    • NEW! Updated Women’s Health chapter features new content and safety highlights
    • NEW! Study and practice questions include the very latest formats for the Next-Generation NCLEX® Exam (NGN)
    • NEW! Protein binding and half-life information is now listed in the Uses/Considerations columns in drug tables
    • UNIQUE! Nursing Process/Clinical Judgment summaries highlight important nursing considerations and clinical judgment skills within the framework of the nursing process
    • UNIQUE! Prototype Drug Charts provide easy access to key information for representative drugs, including dosages, contraindications, drug-lab-food interactions, pharmacokinetics, and more
    • UNIQUE! An extensive Drug Calculations chapter presents six methods of dosage calculation, providing a helpful review and supplement to a dosage calculations textbook
    • Safety and Quality chapter addresses medication errors, specific nursing measures to promote medication safety, U.S. National Patient Safety Goals, the 2021 AACN Essentials, and other safety issues and concerns
    • NGN-Style Case Studies (single-episode and unfolding) provide practice opportunities with the very latest item types
    • Application-level NCLEX®-Style Study Questions at the end of each chapter help prepare you for the growing pharmacology coverage on the NCLEX® Examination.
    • Prioritization coverage helps you learn to prioritize nursing care by listing nursing interventions in the order of priority
    • Clinical Judgment Case Studies (in chapters that do not include NGN-style case studies) challenge you to apply your knowledge and analytical skills to realistic patient scenarios. Answer guidelines are provided on the Evolve website
    • Cultural content is integrated into Nursing Process boxes
  • UNIT I: Introduction to Pharmacology
    1. Clinical Judgment Measurement Model and the Nursing Process
    2. Drug Development and Ethical Considerations
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacogenetics
    5. Complementary and Alternative Therapies
    6. Pediatric Considerations
    7. Geriatric Considerations
    8. Drugs in Substance Use Disorder

    UNIT II: Pharmacotherapy and Drug Administration
    9. Safety and Quality
    10. Drug Administration
    11. Drug Labels and Dosage Calculations

    UNIT III: Maintenance of Homeostasis
    12. Fluid Volume and Electrolytes
    13. Vitamin and Mineral Replacement
    14. Nutritional Support

    UNIT IV: Autonomic Nervous System Drugs
    15. Adrenergic Agonists and Antagonists
    16. Cholinergic Agonists and Antagonists

    NIT V: Central and Peripheral Nervous System Drugs
    17. Stimulants
    18. Depressants
    19. Antiseizure Drugs
    20. Drugs for Parkinsonism and Alzheimer’s Disease
    21. Drugs for Neuromuscular Disorders and Muscle Spasms

    UNIT VI: Mental and Behavioral Health Drugs
    22. Antipsychotics and Anxiolytics
    23. Antidepressants and Mood Stabilizers

    UNIT VII: Pain and Inflammation Management Drugs
    24. Antiinflammatories
    25. Analgesics

    UNIT VIII: Antimicrobial Drugs
    26. Penicillins, Other Beta-Lactams, and Cephalosporins
    27. Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, Ketolides, and Lipopeptides
    28. Tetracyclines, Glycylcyclines, Aminoglycosides, and Fluoroquinolones
    29. Sulfonamides and Nitroimidazoles Antibiotics
    30. Antituberculars, Antifungals, and Antivirals
    31. Antimalarials, Anthelmintics, and Peptides

    UNIT IX: Immunologic Drugs
    32. HIV- and AIDS-Related Drugs
    33. Transplant Drugs
    34. Vaccines

    UNIT X: Antineoplastics and Biologic Response Modifiers
    35. Anticancer Drugs
    36. Targeted Therapies to Treat Cancer
    37. Biologic Response Modifiers

    UNIT XI: Respiratory Drugs
    38. Upper Respiratory Disorders
    39. Lower Respiratory Disorders

    UNIT XII: Cardiovascular Drugs
    40. Cardiac Glycosides, Antianginals, and Antidysrhythmics
    41. Diuretics
    42. Antihypertensives
    43. Anticoagulants, Antiplatelets, and Thrombolytics
    44. Antihyperlipidemics and Drugs to Improve Peripheral Blood Flow

    UNIT XIII: Gastrointestinal Drugs
    45. Gastrointestinal Tract Disorders
    46. Antiulcer Drugs

    UNIT XIV: Eye, Ear, and Skin Drugs
    47. Eye and Ear Disorders
    48. Dermatologic Disorders

    UNIT XV: Endocrine Drugs
    49. Pituitary, Thyroid, Parathyroid, and Adrenal Disorders
    50. Antidiabetics

    UNIT XVI: Renal and Urologic Drugs
    51. Urinary Disorders

    UNIT XVII: Reproductive and Gender-Related Drugs
    52. Pregnancy and Preterm Labor
    53. Labor, Delivery, and Postpartum
    54. Neonatal and Newborn
    55. Women’s Reproductive Health
    56. Men’s Reproductive Disorders
    57. Sexually Transmitted Infections

    UNIT XVIII: Emergency Drugs
    58. Adult and Pediatric Emergency Drugs

    Appendix
    A: Answers to Review Questions
    B: Solution Compatibility Chart
  • Linda E. McCuistion, PhD, MSN, RN, Professor (Ret.), University of Holy Cross, New Orleans, Louisiana, USA, Kathleen Vuljoin DiMaggio, MSN, RN, Professor Emerita, University of Holy Cross, New Orleans, Louisiana, USA, Mary B. Winton, PhD, MSN, RN, Associate Professor, Tarleton State University, Stephenville, Texas, USA and Jennifer J. Yeager, PhD, MSN, RN, Associate Professor, Tarleton State University, Stephenville, Texas, USA
    • Ways of Reading
      • The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
      • This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
      • No information about nonvisual reading is available
    • Conformance
    • Navigation
      • Table of contents to all chapters of the text via links
    • Rich Content
      • No information is available
    • Hazards
      • No information is available
    • Product Content
      • No information is available
    • Legal Considerations
      • No information is available
    • Additional Accessibility Information
      • For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
      • E-publication includes basic navigation (usually less detailed than TOC-based navigation)
      • Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
      • All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
      • The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.
Was $109.99

Now $96.79

Or $0.00 with a valid access code